Is $POSC Heading Into Profitable Territory?
May 5th, 2010 at 1:11 pm Posted by
Positron Corporation (OTC: POSC.OB) is a molecular imaging company focused on nuclear cardiology. $POSC utilizes its proprietary product line to provide unique solutions to the nuclear medicine community, ranging from imaging systems to radiopharmaceutical distribution.
This pharma penny stock has a number of products, including the Attrius, a PET imaging device; the Pulse, a SPECT imagine device; the Nuclear Pharm-Assist, an automated radiopharmaceutical distribution device; and the Tech-Assist, a radiopharmaceutical injection shield.
Over the past couple of weeks, $POSC has seen a stream of news and business developments, including the announcement of a presentation at NASDAQ Marketsite, which is going on right now.
The Dean suggests his students do their homework on $POSC because he suspects volume could come its way this afternoon.
Currently, $POSC is trading at $0.194.
